News & Press Releases

Press Releases

The Insides Company Promoted to NZTE Focus 700

Press Release Source: The Insides Company Limited On: Friday 28 August 2020 Companies: The Insides Company Limited, New Zealand Trade and Enterprise The Insides Company (Insides Co.), a provider of innovative products for patients with intestinal failure, is pleased to be working with New Zealand Trade and Enterprise (NZTE) as a Focus 700 (F700) client. This announcement comes after NZTE…
William Lin
August 28, 2020
Press Releases

University of Auckland Researchers Using The Insides System in Randomised Controlled Trial

Press Release Source: The Insides Company Limited On: Wednesday 19 August 2020 - Auckland Companies: The Insides Company Limited The Insides Company’s premier chyme reinfusion device, The Insides™ Systemfi, has been selected by researchers at the University of Auckland for a pivotal clinical trial. For patients with temporary ileostomies, fluid and nutrient loss is a serious side effect. The Insides…
William Lin
August 28, 2020
News

Faster Recovery From Cancer Surgery

21 April 2020 The following article was originally published by Gilbert Wong as part of The Challenge series, highlighting researchers at The University of Auckland who are tackling big-world problems. It is republished here with permission. A clever device invented here is reducing the recovery time for people who have had surgery for bowel cancer. This saves millions of dollars…
William Lin
July 10, 2020
Press Releases

The Insides Company’s Chyme Reinfusion System features in latest British Journal of Surgery Article

Press Release Source: The Insides Company Limited On: 9:00am Auckland, Monday 20th April 2020 Companies: The Insides Company Limited The Insides Company is delighted to announce the recent publication of the article, “Novel chyme reinfusion device for gastrointestinal fistulas and stomas: feasibility study” under the British Journal of Surgery (BJS), featuring the company’s therapeutic chyme reinfusion solution for the management…
William Lin
April 20, 2020
NewsPress Releases

The InsidesTM Systemfi Cleared for Sale

The Insides™ Systemfi Now Commercially Available in the UK and EU   February 2020 The Insides Company is pleased to announce that The Insides™ Systemfi, an effective chyme reinfusion treatment for enteroatmospheric fistulas and high output enterostomies, is now cleared for sale and commercially available in the United Kingdom and Europe. This critical commercial milestone follows our ISO 13485 certification and…
William Lin
February 1, 2020
News

The Remarkable Kiwi Surgeon Who’s Helped Hundreds in Nepal

This story was originally published on Newsroom.co.nz and is republished with permission. New Zealand surgeon Ian Bissett at Patan, Nepal, in 2010 with a patient he had operated on just three previously at a surgical camp. Photo: Colin Wilson. Every year 33 million people globally are left impoverished after paying for surgery. Others die for lack of treatment. New Zealander Ian Bissett…
William Lin
January 31, 2020
Press Releases

The Insides Company Receives ISO 13485 Certification and CE Mark Approval for Chyme Reinfusion Devices

Press Release Source: The Insides Company Limited On: Friday, 31 January 2020 - Auckland The Insides Company has received ISO 13485 certification and CE mark approval for its chyme reinfusion therapeutic medical device solution. These certifications and approvals mean the device is now cleared for marketing in Europe and the United Kingdom. The Insides Company received the ISO 13485 certification following…
William Lin
January 30, 2020
Press Releases

The Insides Company Rebranded from Surgical Design Studio

Press Release Source: The Insides Company Limited On: Friday 13 December 2019 - Auckland Companies: The Insides Company Limited, Surgical Design Studio Surgical Design Studio, a company developing a chyme reinfusion medical device, announces the complete rebranding to The Insides Company. This rebranding includes a new name, logo, and website. The rebranding initiative reflects the company’s vision to become a global leader in…
William Lin
December 13, 2019
News

The InsidesTM Systemfi Cleared for Sale in New Zealand

The Insides Company is pleased to announce that The Insides™ Systemfi, a therapeutic solution for the management of the morbidities associated with enteroatmospheric fistulas and high output enterostomies, is now cleared for sale and commercially available in New Zealand. This critical commercial milestone follows the completion of multiple certifications, including; IEC 60601 Certification for the safety and performance of medical…
William Lin
October 21, 2019
News

$4.3 million raised by The Insides Company, thanks to Icehouse Ventures

AUCKLAND, August 1, 2019, Medical device developer The Insides Company (TICL) (previously Surgical Design Studio), which designs transformative products that significantly improve the outcomes for patients with bowel cancer and inflammatory bowel disease, has today announced $4.3m has been raised in its first angel fundraising round led by Icehouse Ventures fund, “Tuhua 2.” Founded two years ago at the University…
John Davidson
August 8, 2019

Blog

Patient Case Study for Bowel Continuity Testing

This case report details the use of The InsidesTM Systemfi to rehabilitate “Mary”s1‘ distal bowel, and test functional continence, with the goal of preparing her for reversal of her double-barrel ileostomy, formed as a part of her care pathway to treat multiple internal fistulae secondary to Diverticular disease2.

Click to read more…

Enteroatmospheric Fistula Clinical Case Study

This report presents the case of Ray, a 65-year old male who developed a small bowel enteroatmospheric fistula (EAF) and intra-abdominal sepsis following adhesiolysis surgery for a small bowel obstruction. Ray subsequently spent 5 months in hospital on Total Parenteral Nutrition (TPN) and receiving wound care, while he awaited a fistulotomy. When the surgery failed, Ray was transferred for specialist management at the New Zealand Intestinal Failure Unit, and The InsidesTM Systemfi was introduced to accelerate his recovery.

Click to read more…

Please Don’t Delay, Talk to The Insides Company Today

Since launching, we have received a number of enquiries about our Chyme Reinfusion System from Clinicians who have patients with High Output Enteroatmospheric Fistulas (EAF), only to then be updated that the patient has suffered a severe complication and is no longer available for treatment. High output EAFs are catastrophic conditions with high mortality rates, from 20% to 30% (1).

Click to read more…

What is an Enterocutaneous Fistula and Enteroatmospheric Fistula?

An enterocutaneous fistula (ECF) or an enteroatmospheric fistula (EAF) is a catastrophic complication requiring intense care and optimized nutrition to help accelerate the patient’s journey to recovery.

An ECF is an abnormal connection or tract (fistula) that develops between the intestine (entero) and the skin (cutaneous). An EAF is a special type of ECF where the intestines surface through the skin, exposing the intestines to the atmosphere and external environment (atmospheric).

Click to read more…

What is Chyme?

Chyme (“/kʌɪm/”) is the medical term used to describe the pulpy and semi-fluid composition of partly undigested food, fluid, stomach acid/gastric juices (hydrochloric acid), and digestive enzymes such as pancreatic enzymes and bile. Chyme is initially created in the stomach through both mechanical and chemical processes and passed on into the small intestine for absorption. Chyme is a critical component of gut health and the digestive system. It contains valuable digestive secretions crucial in the maintenance of fluid, electrolyte balance and gut biome.

Click to read more…

What is Chyme Reinfusion?

Chyme Reinfusion (CR) is a practice in the management of patients with High-Output Enterocutaneous Fistulas, and High-Output Enterostomies. Chyme Reinfusion enables patients to reestablish oral feeding and wean off the Parenteral Nutrition (PN) in as little as 3 days (1), resulting in significant health economic benefits and improvements in quality of life (QoL).

Click to read more…

Case Studies

Ray’s Story, Enteroatmospheric Fistula Patient Journey

Ray, a father and grandfather, had been physically active, regularly helped in his community and loved his job as a barber.

Following a routine operation for a small bowel obstruction, Ray developed an Enteroatmospheric Fistula1. Complications including malnutrition and sepsis resulted in a serious deterioration of Ray’s health and many months spent in hospital.

Click to read more…